Vision & mission
Short-term Safety, Tolerability, and Pharmacokinetics of MRX-I, an Oxazolidinone Antibacterial Agent, in Healthy Chinese Subjects.
Time:2018-05-13 / View:468 times
In Vitro and In Vivo Activities of Contezolid (MRX-I) against Mycobacterium tuberculosis
Concentration–response modeling of ECG data from early-phase clinical studies to assess QT prolongation risk of contezolid (MRX-I), an oxazolidinone antibacterial agent